Catalyst Pharmaceuticals Files 8-K
Ticker: CPRX · Form: 8-K · Filed: Apr 9, 2025 · CIK: 1369568
| Field | Detail |
|---|---|
| Company | Catalyst Pharmaceuticals, Inc. (CPRX) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure
TL;DR
Catalyst Pharma filed an 8-K on 4/9 for an event on 4/8. Details pending.
AI Summary
Catalyst Pharmaceuticals, Inc. filed an 8-K on April 9, 2025, reporting an event that occurred on April 8, 2025. The filing is categorized under 'Other Events' and 'Financial Statements and Exhibits'. Specific details regarding the nature of the event or any financial implications were not provided in the excerpt.
Why It Matters
This filing indicates a material event has occurred for Catalyst Pharmaceuticals, requiring public disclosure. Investors should look for further details to understand the event's impact.
Risk Assessment
Risk Level: low — The filing itself is a routine disclosure and does not inherently present a risk, but the underlying event it reports could have varying risk implications.
Key Players & Entities
- CATALYST PHARMACEUTICALS, INC. (company) — Registrant
- April 8, 2025 (date) — Date of Earliest Event Reported
- April 9, 2025 (date) — Date of Report
- 355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134 (address) — Principal Executive Offices
FAQ
What specific event is Catalyst Pharmaceuticals, Inc. reporting in this 8-K filing?
The provided excerpt does not specify the nature of the event reported on April 8, 2025, only that it is categorized under 'Other Events' and 'Financial Statements and Exhibits'.
When was this 8-K form filed with the SEC?
The 8-K form was filed on April 9, 2025.
What is the principal executive office address for Catalyst Pharmaceuticals, Inc.?
The principal executive office is located at 355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134.
What is Catalyst Pharmaceuticals, Inc.'s Central Index Key (CIK)?
Catalyst Pharmaceuticals, Inc.'s Central Index Key is 0001369568.
What is the SEC file number for Catalyst Pharmaceuticals, Inc.?
The SEC file number for Catalyst Pharmaceuticals, Inc. is 001-33057.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2025 regarding CATALYST PHARMACEUTICALS, INC. (CPRX).